129 related articles for article (PubMed ID: 11469530)
1. Anti-cardiolipin antibodies, Raynaud's phenomenon with digital ischemia, and non small cell carcinoma of the lung.
Vaidya S; Logan JW
Scand J Rheumatol; 2001; 30(3):172-4. PubMed ID: 11469530
[TBL] [Abstract][Full Text] [Related]
2. [Raynaud's phenomenon - first sign of malignancy: case report].
Sutić A; Gračanin G; Morović-Vergles J
Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
[TBL] [Abstract][Full Text] [Related]
3. Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.
Tolosa-Vilella C; Ordi-Ros J; Vilardell-Tarres M; Selva-O'Callaghan A; Jordana-Comajuncosa R
Ann Rheum Dis; 1990 Nov; 49(11):935-6. PubMed ID: 2256742
[TBL] [Abstract][Full Text] [Related]
4. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the lung presenting with Raynaud's phenomenon, digital gangrene and multiple infarctions in the internal organs.
Wilmalaratna HS; Sachdev D
Br J Rheumatol; 1987 Dec; 26(6):473-5. PubMed ID: 3690147
[No Abstract] [Full Text] [Related]
6. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Kiener HP; Perkmann T; Koppensteiner R; Schlager O
J Intern Med; 2018 Mar; 283(3):293-302. PubMed ID: 29068146
[TBL] [Abstract][Full Text] [Related]
9. Serological arguments for classifying Raynaud's phenomenon as idiopathic.
Gentric A; Blaschek MA; Le Noach JF; Johanet C; Jouquan J; Lamour A; Abuaf N; Pennec YL; Youinou P
J Rheumatol; 1990 Sep; 17(9):1177-81. PubMed ID: 2290158
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.
Stojan G; Illei PB; Yung RC; Gelber AC
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1263-8. PubMed ID: 24664962
[No Abstract] [Full Text] [Related]
11. Critical peripheral ischemia precipitated by severe episode of Raynaud's phenomenon in a patient with aPL-positive systemic lupus erythematosus, upon high titer anti-RNP seroconversion.
Levy O; Maslakov I; Vosco S; Markov A; Amit-Vazina M; Tishler M
Lupus; 2015 Mar; 24(3):327-30. PubMed ID: 25467391
[TBL] [Abstract][Full Text] [Related]
12. Raynaud's phenomenon: primary and secondary causes.
Balas P; Tripolitis AJ; Kaklamanis P; Mandalaki T; Paracharalampous N
Arch Surg; 1979 Oct; 114(10):1174-7. PubMed ID: 485828
[TBL] [Abstract][Full Text] [Related]
13. Raynaud's phenomenon.
Lally EV
Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
[TBL] [Abstract][Full Text] [Related]
14. Occlusive digital artery disease in patients with Raynaud's phenomenon.
Zweifler AJ; Trinkaus P
Am J Med; 1984 Dec; 77(6):995-1001. PubMed ID: 6334442
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum of Raynaud's phenomenon in patients referred to vascular clinic.
Knapik-Kordecka M; Wysokinski WE
Cardiovasc Surg; 2000 Oct; 8(6):457-62. PubMed ID: 10996100
[TBL] [Abstract][Full Text] [Related]
17. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic thoracic sympathicotomy for Raynaud's phenomenon.
Matsumoto Y; Ueyama T; Endo M; Sasaki H; Kasashima F; Abe Y; Kosugi I
J Vasc Surg; 2002 Jul; 36(1):57-61. PubMed ID: 12096258
[TBL] [Abstract][Full Text] [Related]
19. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
